SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs sharp rally is drawing attention after bullish Morgan Stanley commentary and Starship-related catalysts, including a proposed Florida fuel pipeline and upcoming flight milestones; traders also cite the companys AI ambitions. Bulls are celebrating the breakout and possible short covering, while skeptics warn that the valuation is stretched and upcoming share unlocks could add selling pressure.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

NVAXs sharp rally is being tied by traders to reports of a suspected plague exposure at a Russian research facility, with some speculating about renewed vaccine demand; others caution the bacterial outbreak does not directly establish a role for Novavax. High reported short interest is fueling short-squeeze talk, while traders also point to the companys vaccine approvals and Sanofi/Takeda partnerships as alternative explanations for the move.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is drawing attention amid a sharp share-price decline and continued uncertainty over how it will finance its AI data-center projects, with traders debating potential dilution and whether announced contracts will translate into revenue and cash flow. Bulls point to Yotta deployments and the companys contract pipeline, while skeptics say execution and clearer financing disclosures are needed to restore confidence.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zetas strong momentum and recent highs are drawing attention, with traders focused on Zeta Live announcements, analyst optimism, and expected earnings strength tied to its AI-driven marketing platform and partnerships. Bulls expect the catalysts to support further gains, while others warn of profit-taking, a pullback, or dilution concerns.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

ICP is drawing attention as traders debate whether its recent advance can break through a key resistance area and sustain a breakout; bulls point to improving momentum, while skeptics cite repeated rejections and weak follow-through. Supporters also highlight the projects AI and decentralized-computing ambitions and reported government use cases in Pakistan, though others remain unconvinced about adoption and token performance.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Traders are focused on RIOTs repeated underperformance against Bitcoin and peer miners, with some blaming dilution or short-selling and others pointing to broader weakness across crypto and data-center stocks. The main bullish counterpoint is Riots AI/HPC data-center pivot and contracted Rockdale capacity, while traders debate whether further Corsicana leasing news can offset concerns about execution and the stocks muted reaction to positive developments.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPEs rally toward fresh highs has traders focused on the protocols fee-funded buybacks and burns, alongside growing trading activity. Many are celebrating the momentum, while others warn of volatility, profit-taking and token-unlock supply.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRXs high-volume breakout is drawing attention, with traders linking optimism to Michael Caputos appointment to the Presidents Cancer Panel and his engagement with ImmunityBio founder Patrick Soon-Shiong; broader access to Anktiva remains speculation. Many are also debating whether heavy short interest and options activity could amplify the move, while others note there was no new company announcement to explain the trading surge.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Michael Burrys new DECK position as a temporary proxy for Lululemon during a tax-loss wash-sale period is drawing attention. Some traders see his move as validation of Deckers value, while others doubt his track record and remain wary amid weakness across footwear stocks.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Department of War grant to help convert a U.S. battery line for drone-cell production is the main catalyst drawing attention. Traders view the funding and domestic manufacturing plans as a long-term vote of confidence, but debate whether they will lead to near-term orders or revenue; frustration is widespread that an initial share-price pop quickly faded.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

US tariffs on metals and pharma: Which Indian stocks are safe and which aren't: Sudip Bandyopadhyay

Indian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical sectors. Expert Sudip Bandyopadhyay provides stock-specific insights. Vedanta and NALCO are well-positioned in aluminium. Tata Steel faces uncertainty due to European operations. Sun Pharma and Glenmark are at risk in the pharmaceutical sector due to branded drug exposure.

Indian Bank, Cummins, Glenmark Pharma: 3 stocks ideas for near-term gains, check targets

… suggested three stocks including Glenmark Pharmaceuticals Ltd, Cummins India and Indian … , supporting further upside potential. Glenmark Pharmaceuticals | Buy | Target Price: Rs 2 … Loss: Rs 1,988 Glenmark Pharma is displaying a constructive bullish setup …

Glenmark Pharmaceuticals Launches GLIPIQ® (Semaglutide) In India

… (Glenmark), a research-led, global pharmaceutical company, today announced the launch of … been approved by the Central Drugs Standard Control Organization (CDSCO) … Business Head, India Formulations, Glenmark Pharmaceuticals Ltd., said, "Affordability …

Glenmark Debuts Budget Semaglutide In India, Undercutting Ozempic By Over 80%

Equity

As the patents for semaglutide near expiry in several countries this month, India has introduced a cost-effective alternative.


Rs 325–4,200/month: Dr Reddy’s, Sun Pharma, Glenmark kick off generic semaglutide price war

… Reddy’s Laboratories, Sun Pharma , Glenmark Pharmaceuticals , Alkem Laboratories, Zydus Lifesciences … , and Natco Pharma . Eris Lifesciences, which has a … first Indian pharma company to receive approval from the Drugs Controller General …

Sun Pharma, Dr Reddy's, Glenmark Launch Generic Semaglutide Injection in India

… markets." Another homegrown pharma major, Glenmark Pharmaceuticals Ltd also launched its …

Will Trump’s 100% Tariffs Derail Indian Pharma Stocks? SEBI Analyst Flags Key Levels For Traders

The new U.S. duty has already triggered a slide in major Asian pharma names, raising concerns about how Indian peers will react in the coming weeks.

Trading Radar For September 25: Tata Motors, Lupin, Glenmark, Polycab, Swan Defence Stocks Are On Investors’ Watchlist

Ivalue Infosolutions set to list on the mainboard today

Adani Ports, TCS, Glenmark Among SEBI Analyst’s Breakout Calls 

The analyst highlights breakout opportunities in these stocks, provided that critical support levels are maintained.

Glenmark Pharmaceuticals Shares Gain 3% After Launching Phase 3 Lung Cancer Drug Trial

The company has submitted a Clinical Trial Application to start the study in Russia and is preparing sites in Brazil and Mexico

Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. It operates through the following geographical segments: India, North America, Europe, Latin America, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.

Current Price	2,295.00
Prev Close	2,284.40
Open	2,325.00
Dividend Yield	0.23%
50-Day Moving Average	2,359.31
Beta	0.03
Avg. Volume	558,727.29
PE Ratio	36.02

52-Week High	2,537.60
52-Week Low	1,792.60
Market Capitalization	659.36B
EPS (Annual)	48.26
Price to Book	6.16
Revenue Per Employee	9.55M

Feed

News

Sentiment

Earnings

Fundamentals

Info

GLENMARK.NSE Fundamentals